Elicio Therapeutics, Inc. (ELTX) Gross profit 2020–2022
Elicio Therapeutics, Inc. (ELTX) annual gross profit history from SEC filings — each fiscal year as reported.
$2.3MFY2022 · since FY2020: $1.7M → $2.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $2.3M | -91.7% |
| FY2021 | $27.9M | +1549.6% |
| FY2020 | $1.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ELTX financial trends
ELTX RevenueELTX Net incomeELTX Net marginELTX Gross marginELTX Operating incomeELTX Operating marginELTX Operating cash flowELTX Free cash flowELTX Capital expendituresELTX Return on equityELTX Stock buybacksELTX Dividends paidELTX Total assetsELTX Total liabilitiesELTX Shareholders’ equityELTX overview →